Morris Capital Advisors’s Biogen BIIB Stock Holding History

Morris Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,606	Closed	-$456K	–	60
2020 Q3	$456K	Sell	1,606 -48	-3%	-$13.4K	0.4%	44
2020 Q2	$443K	Buy	1,654 +14	+0.9%	+$4.21K	0.4%	44
2020 Q1	$519K	Sell	1,640 -37	-2%	-$11.2K	0.56%	36
2019 Q4	$498K	Sell	1,677 -38	-2%	-$10.5K	0.42%	47
2019 Q3	$399K	Hold	1,715	–	–	0.35%	47
2019 Q2	$401K	Hold	1,715	–	–	0.33%	48
2019 Q1	$405K	Sell	1,715 -9	-0.5%	-$2.83K	0.32%	50
2018 Q4	$519K	Sell	1,724 -62	-3%	-$19.8K	0.44%	36
2018 Q3	$631K	Sell	1,786 -40	-2%	-$13.8K	0.42%	36
2018 Q2	$530K	Hold	1,826	–	–	0.37%	44
2018 Q1	$500K	Buy	1,826 +20	+1%	+$6.21K	0.33%	47
2017 Q4	$575K	Buy	1,806 +4	+0.2%	+$1.28K	0.38%	45
2017 Q3	$564K	Buy	+1,802	New	+$534K	0.38%	44

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morris Capital Advisors's BIIB Position: Q4 2020 in Review

Morris Capital Advisors sold out of Biogen (BIIB) in Q4 2020, closing a stake of 1,606 shares — an estimated $456K sold.

Morris Capital Advisors first reported a position in BIIB in Q3 2017 and held it in 13 quarters. The position peaked at $631K in Q3 2018. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

Morris Capital Advisors reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
Morris Capital Advisors sold 1,606 Biogen shares in Q4 2020, an estimated $456K.
Morris Capital Advisors first reported a position in Biogen in Q3 2017 and held it in 13 quarters.
Morris Capital Advisors's Biogen position peaked at $631K in Q3 2018.
1,062 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Morris Capital Advisors's 13F filing for Q4 2020, filed 19 Jan 2021.